Apolipoprotein C-III in patients with systemic lupus erythematosus

Abstract Background Systemic lupus erythematosus (SLE) has been associated with atherosclerotic cardiovascular disease (CV) and an altered lipid profile. High levels of apolipoprotein C-III (ApoC3) are associated with elevated triglyceride levels and an increased risk of CV. In the present study, we...

Full beskrivning

Sparad:
Bibliografiska uppgifter
Huvudupphovsmän: Candelaria Martín-González, Carmen Ferrer-Moure, Juan Carlos Quevedo-Abeledo, Antonia de Vera-González, Alejandra González-Delgado, Julio Sánchez-Martín, Miguel Á. González-Gay, Iván Ferraz-Amaro
Materialtyp: Artigo
Språk:Inglês
Publicerad: BMC 2022-05-01
Serie:Arthritis Research & Therapy
Ämnen:
Systemic lupus erythematosus
Apolipoprotein C3
Länkar:https://doi.org/10.1186/s13075-022-02793-y
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk